162 related articles for article (PubMed ID: 34547134)
1. LncRNA SCIRT absorbs miR-221 to advance the expression of lncRNA GAS5 in oral squamous cell carcinoma to inhibit cancer cell apoptosis.
Yang L; Yang K; Wang H; Chen Y; Zhao J
J Oral Pathol Med; 2022 Mar; 51(3):256-262. PubMed ID: 34547134
[TBL] [Abstract][Full Text] [Related]
2. LncRNA SCIRT is Downregulated in Acute Myeloid Leukemia and Sponges miR-21 in Cytoplasm to Increase Chemosensitivity to Doxorubicin.
Li H; Tian X; Nie T; Huang M; Xiao Z
Crit Rev Eukaryot Gene Expr; 2022; 32(3):61-69. PubMed ID: 35695610
[TBL] [Abstract][Full Text] [Related]
3. Exosome-mediated long noncoding RNA (lncRNA) PART1 suppresses malignant progression of oral squamous cell carcinoma via miR-17-5p/SOCS6 axis.
Du Y; Shuai Y; Wang H; Li H; Li Y
Turk J Med Sci; 2023 Jun; 53(3):630-639. PubMed ID: 37476905
[TBL] [Abstract][Full Text] [Related]
4. LncRNA GAS5 suppresses proliferation, migration, invasion, and epithelial-mesenchymal transition in oral squamous cell carcinoma by regulating the miR-21/PTEN axis.
Zeng B; Li Y; Jiang F; Wei C; Chen G; Zhang W; Zhao W; Yu D
Exp Cell Res; 2019 Jan; 374(2):365-373. PubMed ID: 30576678
[TBL] [Abstract][Full Text] [Related]
5. LncRNA SCIRT is downregulated in atherosclerosis and suppresses the proliferation of human aortic smooth muscle cells (HAOSMCs) by sponging miR-146a in cytoplasm.
Gao W; Li R; Yu J; He X; Xu D; Zhong H; Dong W; Cui H
J Cardiothorac Surg; 2021 Nov; 16(1):324. PubMed ID: 34742341
[TBL] [Abstract][Full Text] [Related]
6. LncRNA UCA1 promotes proliferation and cisplatin resistance of oral squamous cell carcinoma by sunppressing miR-184 expression.
Fang Z; Zhao J; Xie W; Sun Q; Wang H; Qiao B
Cancer Med; 2017 Dec; 6(12):2897-2908. PubMed ID: 29125238
[TBL] [Abstract][Full Text] [Related]
7. lncRNA HOXA11-AS maintains the stemness of oral squamous cell carcinoma stem cells and reduces the radiosensitivity by targeting miR-518a-3p/PDK1.
Li B; Lv Y; Zhang C; Xiang C
J Oral Pathol Med; 2023 Mar; 52(3):216-225. PubMed ID: 36661031
[TBL] [Abstract][Full Text] [Related]
8. Analysis of the subcellular location of lncRNA SLC16A1-AS1 and its interaction with premature miR-5088-5p in oral squamous cell carcinoma.
Li T; Wang D; Yang S
Odontology; 2023 Jan; 111(1):41-48. PubMed ID: 35829849
[TBL] [Abstract][Full Text] [Related]
9. Mechanism of METTL14 and m6A modification of lncRNA MALAT1 in the proliferation of oral squamous cell carcinoma cells.
Li J; Momen-Heravi F; Wu X; He K
Oral Dis; 2023 Jul; 29(5):2012-2026. PubMed ID: 35467063
[TBL] [Abstract][Full Text] [Related]
10. Down-regulation of lncRNA HCG11 promotes cell proliferation of oral squamous cell carcinoma through sponging miR-455-5p.
Wu J; Li Y; Liu J; Xu Y
J Gene Med; 2021 Mar; 23(3):e3293. PubMed ID: 33151000
[TBL] [Abstract][Full Text] [Related]
11. LncRNA GACAT1 targeting miRNA-149 regulates the molecular mechanism of proliferation, apoptosis and autophagy of oral squamous cell carcinoma cells.
Chen J; Chen X; Fu L; Chen J; Chen Y; Liu F
Aging (Albany NY); 2021 Aug; 13(16):20359-20371. PubMed ID: 34460438
[TBL] [Abstract][Full Text] [Related]
12. GAS5 alleviates cisplatin drug resistance in oral squamous cell carcinoma by sponging miR-196a.
Yuan X; Jing Y; Guang M; Zhu J; Wang J; Wang Y; Zhang Y
J Int Med Res; 2022 Oct; 50(10):3000605221132456. PubMed ID: 36310502
[TBL] [Abstract][Full Text] [Related]
13. Long noncoding RNA SNHG20 regulates cell migration, invasion, and proliferation via the microRNA-19b-3p/RAB14 axis in oral squamous cell carcinoma.
Zhu X; Zhang H; Xu J
Bioengineered; 2021 Dec; 12(1):3993-4003. PubMed ID: 34282711
[TBL] [Abstract][Full Text] [Related]
14. LncRNA DANCR regulates the growth and metastasis of oral squamous cell carcinoma cells via altering miR-216a-5p expression.
Qu XH; Shi YL; Ma Y; Bao WW; Yang L; Li JC; Zhang F
Hum Cell; 2020 Oct; 33(4):1281-1293. PubMed ID: 32860589
[TBL] [Abstract][Full Text] [Related]
15. Long non-coding RNA CCAT1 is a prognostic biomarker for the progression of oral squamous cell carcinoma via miR-181a-mediated Wnt/β-catenin signaling pathway.
Li GH; Ma ZH; Wang X
Cell Cycle; 2019 Nov; 18(21):2902-2913. PubMed ID: 31599709
[TBL] [Abstract][Full Text] [Related]
16. LncRNA JPX overexpressed in oral squamous cell carcinoma drives malignancy via miR-944/CDH2 axis.
Yao Y; Chen S; Lu N; Yin Y; Liu Z
Oral Dis; 2021 May; 27(4):924-933. PubMed ID: 32881231
[TBL] [Abstract][Full Text] [Related]
17. LncRNA NORAD facilitates oral squamous cell carcinoma progression by sponging miR-577 to enhance TPM4.
Qi C; Liu J; Guo P; Xu Y; Hu J; Han X
Biol Direct; 2022 Jan; 17(1):1. PubMed ID: 34991683
[TBL] [Abstract][Full Text] [Related]
18. LncRNA GAS5/miR‑4465 axis regulates the malignant potential of nasopharyngeal carcinoma by targeting COX2.
Zhong Q; Wang Z; Liao X; Wu R; Guo X
Cell Cycle; 2020 Nov; 19(22):3004-3017. PubMed ID: 33092435
[TBL] [Abstract][Full Text] [Related]
19. lncRNA NR2F2-AS1 inhibits the methylation of miR-494 to regulate oral squamous cell carcinoma cell proliferation.
Liang Y; Wu X; Lee J; Yu D; Su J; Guo M; Meng N; Qin J; Fan X
Arch Oral Biol; 2022 Feb; 134():105316. PubMed ID: 34896865
[TBL] [Abstract][Full Text] [Related]
20. LncRNA XIST promotes proliferation and cisplatin resistance of oral squamous cell carcinoma by downregulating miR-27b-3p.
Ma SQ; Wang YC; Li Y; Li XY; Yang J; Sheng YM
J Biol Regul Homeost Agents; 2020; 34(6):1993-2001. PubMed ID: 33191714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
